The Chief Executive Officer of Rocket Pharmaceuticals, Dr. Gaurav Shah, has executed a sale of company stock valued at $171,840. This transaction was reported in a filing with the Securities and Exchange Commission. The sale reflects a portion of Shah's holdings in the company, which is engaged in the development of gene therapies for rare diseases.
Related Articles
Don't miss out on breaking stories and in-depth articles.